Celularity Inc. (CELU) NASDAQ
$3.09 (0.12) (-3.74%)
Market Cap: $694.66M
As of 04/19/24 02:17 PM EDT. Market closed.
Celularity Inc. (CELU)
NASDAQ
$3.09
(0.12) (-3.74%)
Market Cap: $694.66M
As of 04/19/24 02:17 PM EDT. Market closed.
Add to Portfolio
Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) ... read more
Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Robert Joseph Hariri
Full Time Employees
225
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Robert Joseph Hariri
Full Time Employees
225
Address
170 Park Avenue, NJ, Florham Park, 07932.
PRICE CHART FOR CELULARITY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.21
Previous Close
$3.21
Days Range
$3.18 - $3.30
52 week range
$1.59 - $8.90
Volume
23,520
Avg. Volume (30 days)
45,504
Market Cap
$694.66M
Dividend Yield
-
P/E
(3.83)
Shares Outstanding
216,406,240
Open
$3.21
Previous Close
$3.21
Days Range
$3.18 - $3.30
52 week range
$1.59 - $8.90
Volume
23,520
Avg. Volume (30 days)
45,504
Market Cap
$694.66M
Dividend Yield
-
P/E
(3.83)
Shares Outstanding
216,406,240
FINANCIAL STATEMENTS FOR CELULARITY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CELULARITY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Fletcher Kyle | See Remarks | Apr 13, 2024 | Option Exercise | $4.11 | 20 | 82 | 21,085 | Apr 16, 2024, 08:56 PM |
| Haines John R | See Remarks | Apr 13, 2024 | Option Exercise | $4.11 | 576 | 2,367 | 38,373 | Apr 16, 2024, 08:56 PM |
| Beers David C | Chief Financial Officer | Apr 13, 2024 | Option Exercise | $4.11 | 360 | 1,480 | 23,983 | Apr 16, 2024, 08:56 PM |
| Hariri Robert J | Chief Executive Officer | Apr 13, 2024 | Option Exercise | $4.11 | 1,154 | 4,743 | 2,855,889 | Apr 16, 2024, 08:56 PM |
| Brigido Stephen | Pres, Functional Regeneration | Apr 13, 2024 | Option Exercise | $4.11 | 268 | 1,101 | 19,472 | Apr 16, 2024, 08:56 PM |
| Fletcher Kyle | See Remarks | Mar 15, 2024 | Option Exercise | $5.68 | 617 | 3,505 | 21,105 | Mar 19, 2024, 09:20 AM |
| Kilcoyne Adrian | Chief Medical Officer | Feb 17, 2024 | Option Exercise | $0.43 | 52,762 | 22,899 | 1,122,238 | Feb 21, 2024, 09:38 PM |
| Haines John R | See Remarks | Feb 17, 2024 | Option Exercise | $0.43 | 70,350 | 30,532 | 389,497 | Feb 21, 2024, 09:22 PM |
| Beers David C | Chief Financial Officer | Feb 17, 2024 | Option Exercise | $0.43 | 43,968 | 19,082 | 243,437 | Feb 21, 2024, 09:18 PM |
| Brigido Stephen | Pres, Functional Regeneration | Feb 17, 2024 | Option Exercise | $0.43 | 32,720 | 14,200 | 197,406 | Feb 21, 2024, 09:14 PM |
| Fletcher Kyle | See Remarks | Feb 17, 2024 | Option Exercise | $0.43 | 39,571 | 17,174 | 217,228 | Feb 21, 2024, 09:10 PM |
| Lim Kok Thay | 10% Owner | Jan 12, 2024 | Buy | $0.25 | 21,410,983 | 5,331,335 | 51,473,762 | Jan 17, 2024, 05:22 PM |
| Hariri Robert J | Chief Executive Officer | Sep 29, 2023 | Buy | $0.17 | 9,064,539 | 1,500,181 | 19,212,849 | Oct 10, 2023, 09:48 PM |
| Hariri Robert J | Chief Executive Officer | Oct 05, 2023 | Buy | $0.16 | 9,357,585 | 1,484,113 | 28,570,434 | Oct 10, 2023, 09:48 PM |
| Lim Kok Thay | Director | Jun 14, 2023 | Option Exercise | $0.75 | 10,844 | 8,136 | 225,222 | Jun 30, 2023, 07:19 PM |
| Brigido Stephen | Pres, Functional Regeneration | Apr 13, 2023 | Option Exercise | $0.71 | 2,683 | 1,916 | 230,126 | Apr 17, 2023, 09:23 PM |
| Fletcher Kyle | See Remarks | Apr 13, 2023 | Option Exercise | $0.71 | 201 | 144 | 256,799 | Apr 17, 2023, 09:20 PM |
| Hariri Robert J | Chief Executive Officer | Apr 13, 2023 | Option Exercise | $0.71 | 11,540 | 8,241 | 10,148,310 | Apr 17, 2023, 09:19 PM |
| Beers David C | Chief Financial Officer | Apr 13, 2023 | Option Exercise | $0.71 | 3,606 | 2,575 | 287,405 | Apr 17, 2023, 09:17 PM |
| Haines John R | See Remarks | Apr 13, 2023 | Option Exercise | $0.71 | 5,770 | 4,120 | 459,847 | Apr 17, 2023, 09:16 PM |
| Glover Bradley | See Remarks | Apr 13, 2023 | Option Exercise | $0.71 | 2,884 | 2,059 | 351,192 | Apr 17, 2023, 09:12 PM |
| Fletcher Kyle | See Remarks | Mar 15, 2023 | Option Exercise | $0.63 | 2,170 | 1,365 | 257,000 | Mar 30, 2023, 04:05 PM |
| Hariri Robert J | Chief Executive Officer | Mar 27, 2023 | Option Exercise | $0.83 | 2,084,854 | 1,739,394 | 10,159,850 | Mar 27, 2023, 08:27 PM |
| Diamandis Peter | Director | Feb 10, 2023 | Option Exercise | $0.28 | 1,071,000 | 299,880 | 1,107,145 | Feb 14, 2023, 07:24 PM |
| Hariri Robert J | Chief Executive Officer | Nov 30, 2022 | Buy | $1.72 | 10,000 | 17,175 | 8,074,996 | Nov 30, 2022, 07:55 PM |
| Hariri Robert J | Chief Executive Officer | Nov 29, 2022 | Buy | $1.71 | 40,000 | 68,400 | 8,064,996 | Nov 29, 2022, 07:53 PM |
| Hariri Robert J | Chief Executive Officer | Nov 28, 2022 | Buy | $1.74 | 40,000 | 69,600 | 8,024,996 | Nov 28, 2022, 07:13 PM |
| Jones Anne | Chief Business Officer | Nov 16, 2022 | Option Exercise | $1.89 | 3,734 | 7,057 | 49,154 | Nov 18, 2022, 08:16 PM |
| Fletcher Kyle | General Counsel | Nov 16, 2022 | Option Exercise | $1.89 | 1,262 | 2,385 | 34,170 | Nov 18, 2022, 08:16 PM |
| Glover Bradley | See Remarks | Nov 16, 2021 | Option Exercise | $1.89 | 3,734 | 7,057 | 54,076 | Nov 18, 2022, 08:16 PM |
| SCULLEY JOHN | Director | Aug 26, 2022 | Option Exercise | $0.28 | 768,594 | 215,206 | 804,739 | Aug 30, 2022, 08:52 PM |
| Hariri Robert J | Chief Executive Officer | Aug 24, 2022 | Option Exercise | $2.87 | 119,073 | 341,739 | 7,984,996 | Aug 25, 2022, 09:14 PM |
| STARR INTERNATIONAL CO INC | 10% Owner | Mar 01, 2022 | Option Exercise | $3.50 | 6,640,694 | 23,242,429 | 15,281,389 | Mar 15, 2022, 05:40 PM |
| VON ESCHENBACH ANDREW C. | Director | Nov 09, 2021 | Option Exercise | $0.28 | 100,000 | 28,000 | 100,000 | Dec 02, 2021, 09:44 PM |
| Lim Kok Thay | Director | Jul 16, 2021 | Option Exercise | $10.00 | 3,500,000 | 35,000,000 | 30,062,778 | Jul 20, 2021, 09:09 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Fletcher Kyle | See Remarks | 04/13/2024 | 82 |
| Haines John R | See Remarks | 04/13/2024 | 2,367 |
| Beers David C | Chief Financial Officer | 04/13/2024 | 1,480 |
| Hariri Robert J | Chief Executive Officer | 04/13/2024 | 4,743 |
| Brigido Stephen | Pres, Functional Regeneration | 04/13/2024 | 1,101 |
| Fletcher Kyle | See Remarks | 03/15/2024 | 3,505 |
| Kilcoyne Adrian | Chief Medical Officer | 02/17/2024 | 22,899 |
| Haines John R | See Remarks | 02/17/2024 | 30,532 |
| Beers David C | Chief Financial Officer | 02/17/2024 | 19,082 |
| Brigido Stephen | Pres, Functional Regeneration | 02/17/2024 | 14,200 |
| Fletcher Kyle | See Remarks | 02/17/2024 | 17,174 |
| Lim Kok Thay | 10% Owner | 01/12/2024 | 5,331,335 |
| Hariri Robert J | Chief Executive Officer | 09/29/2023 | 1,500,181 |
| Hariri Robert J | Chief Executive Officer | 10/05/2023 | 1,484,113 |
| Lim Kok Thay | Director | 06/14/2023 | 8,136 |
| Brigido Stephen | Pres, Functional Regeneration | 04/13/2023 | 1,916 |
| Fletcher Kyle | See Remarks | 04/13/2023 | 144 |
| Hariri Robert J | Chief Executive Officer | 04/13/2023 | 8,241 |
| Beers David C | Chief Financial Officer | 04/13/2023 | 2,575 |
| Haines John R | See Remarks | 04/13/2023 | 4,120 |
| Glover Bradley | See Remarks | 04/13/2023 | 2,059 |
| Fletcher Kyle | See Remarks | 03/15/2023 | 1,365 |
| Hariri Robert J | Chief Executive Officer | 03/27/2023 | 1,739,394 |
| Diamandis Peter | Director | 02/10/2023 | 299,880 |
| Hariri Robert J | Chief Executive Officer | 11/30/2022 | 17,175 |
| Hariri Robert J | Chief Executive Officer | 11/29/2022 | 68,400 |
| Hariri Robert J | Chief Executive Officer | 11/28/2022 | 69,600 |
| Jones Anne | Chief Business Officer | 11/16/2022 | 7,057 |
| Fletcher Kyle | General Counsel | 11/16/2022 | 2,385 |
| Glover Bradley | See Remarks | 11/16/2021 | 7,057 |
| SCULLEY JOHN | Director | 08/26/2022 | 215,206 |
| Hariri Robert J | Chief Executive Officer | 08/24/2022 | 341,739 |
| STARR INTERNATIONAL CO INC | 10% Owner | 03/01/2022 | 23,242,429 |
| VON ESCHENBACH ANDREW C. | Director | 11/09/2021 | 28,000 |
| Lim Kok Thay | Director | 07/16/2021 | 35,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CELULARITY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 978,106 | 0.00003% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 843,474 | 0.00032% | 55.22% | Other |
| BLACKROCK INC. | 771,410 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR CELULARITY INC
STOCK BUYBACKS FOR CELULARITY INC
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
6.66%
1Q
03/31/2023
21.21%
2Q
12/31/2022
25.69%
3Q
09/30/2022
25.09%
4Q
06/30/2022
24.46%
5Q
03/31/2022
44.42%
6Q
09/30/2021
52.38%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CELULARITY INC
LOADING...